Raniviz TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ranibizumab
Brand name
(ARTG)
: RANIVIZ ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection pre-filled syringeWhat this medicine is used for
(ARTG)
Raniviz (ranibizumab) is indicated in adults for:, the treatment of neovascular (wet) age-related macular degeneration (AMD),, the treatment of visual impairment due to diabetic macular oedema (DME),, treatment of proliferative diabetic retinopathy (PDR),, the treatment of visual impairment due to choroidal neovascularisation,, the treatment of visual impairment due to choroidal neovascularisation (CNV) secondary to pathologic myopia (PM),, the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO).,Not recommended for use in preterm infants.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravitreal-Within The Vitreous Cavity Of The Eye
- Clear, colourless to pale yellow, aqueous solution in a pre-filled syringe
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranibizumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
